Related Experiment Video
Updated: Sep 28, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Rapid turnover of cell-cycle regulators found in Mirk/dyrk1B transfectants
Daina Z Ewton1, Kangmoon Lee, Xiaobing Deng
1Pathology Department, Upstate Medical University, State University of New York, Syracuse, NY 13210, USA.
Abstract:
Mirk/dyrk1B is an arginine-directed protein kinase, which functions as a transcriptional activator and mediates serum-free growth of colon carcinoma cells by an unknown mechanism. We now report that turnover of the cdk inhibitor p27(kip1) and the G(1)-phase cyclin cyclin D1 is enhanced in each of 4 Mirk stable transfectants compared to vector control transfectants and Mirk kinase-inactive mutant transfectants. This enhanced turnover is proteasome-dependent and leads to lower protein levels of both p27(kip1) and cyclin D1. Lower protein levels of the cdk inhibitor p21(cip1) were also observed in the 4 Mirk stable transfectants. Mirk did not alter the activity of a p27(kip1) promoter construct or p27(kip1) mRNA levels by stable expression, indicating that the decrease in p27(kip1) protein levels was due to a posttranscriptional mechanism. These data are consistent with mirk enhancing the expression of some component common to the proteolysis of both p27(kip1) and cyclin D1.
Insights
Mirk/dyrk1B protein kinase enhances colon carcinoma cell growth by promoting the proteasomal degradation of cell cycle inhibitors p27(kip1) and p21(cip1), and cyclin D1. This posttranscriptional regulation accelerates cell proliferation.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Mirk/dyrk1B is a protein kinase regulating gene transcription and colon carcinoma cell growth.
- The precise mechanism by which Mirk influences cell proliferation remains largely unknown.
Purpose of the Study:
- To elucidate the molecular mechanism by which Mirk/dyrk1B promotes colon carcinoma cell growth.
- To investigate the effect of Mirk on key cell cycle regulatory proteins.
Main Methods:
- Stable transfectants expressing wild-type Mirk or kinase-inactive Mirk mutants were generated.
- Protein levels of cyclin-dependent kinase (CDK) inhibitors (p27(kip1), p21(cip1)) and G1-phase cyclin D1 were analyzed.
- Proteasomal degradation was assessed.
- Analysis of p27(kip1) promoter activity and mRNA levels was performed.
Main Results:
- Mirk expression enhanced the proteasome-dependent turnover of p27(kip1) and cyclin D1, leading to their decreased protein levels.
- Lower protein levels of p21(cip1) were also observed in Mirk-expressing cells.
- Mirk did not affect p27(kip1) mRNA levels or promoter activity, indicating posttranscriptional regulation.
- These findings suggest Mirk enhances a common component involved in the proteolysis of p27(kip1) and cyclin D1.
Conclusions:
- Mirk/dyrk1B kinase activity promotes colon carcinoma cell proliferation through the posttranscriptional downregulation of cell cycle inhibitors p27(kip1), p21(cip1), and cyclin D1.
- The enhanced degradation is proteasome-dependent and suggests Mirk targets a shared regulatory pathway for these proteins.
- Further research is warranted to identify the specific proteasomal components modulated by Mirk.
Related Concept Videos
Positive Regulator Molecules
Positive Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Negative Regulator Molecules
Mitogens and the Cell Cycle
Inhibition of Cdk Activity

